Servier
Approved Evidence
Added to Rotten Company: 8/21/2026
Conduct/Event period: 2005–2007
Ongoing: No
Resolution status: Resolved
Resolution date: June 27, 2024
Servier Fined Hundreds of Millions of Euros Over Pay-for-Delay Agreements
Summary
The European Commission found that Servier entered agreements with generic drug manufacturers that restricted competition around the blood-pressure medicine perindopril. The Commission originally imposed fines on Servier totaling approximately €331 million. Litigation subsequently changed parts of the decision and reduced the amount, while EU court proceedings upheld core findings concerning anticompetitive agreements. The Court of Justice's 2024 judgment addressed the remaining appeals. Sources: Court of Justice of the European Union / EUR-Lex https://eur-lex.europa.eu/legal-content/FR/TXT/PDF/?uri=CELEX:62019CJ0176_RES Court of Justice press material https://curia.europa.eu/jcms/upload/docs/application/pdf/2018-12/cp180194fr.pdf
Evidence Weight
100.00
Severity: high
Recency Weight: 99.9966220139967
File Weight: 1